INVESTOR ALERT: Securities Class Action Filed Against Capricor Therapeutics, Inc. – Investors Encouraged to Contact Kirby McInerney LLP
Kirby McInerney LLP announced the filing of a class action lawsuit against Capricor Therapeutics on behalf of investors who acquired stock between December 17, 2025 and July 26, 2026. The complaint alleges that Capricor made materially false statements regarding changes to the statistical analysis plan for Deramiocel and failed to disclose the FDA had not agreed to those changes.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.